| 1 |
32166948 | Glutathione-Specific and Intracellularly Labile Polymeric Nanocarrier for Efficient and Safe Cancer Gene Delivery. | 2020 Apr 1 |
2 |
| 2 |
32251770 | Improved melanoma suppression with target-delivered TRAIL and Paclitaxel by a multifunctional nanocarrier. | 2020 Sep 10 |
6 |
| 3 |
33200709 | Paclitaxel Priming of TRAIL Expressing Mesenchymal Stromal Cells (MSCs-TRAIL) Increases Antitumor Efficacy of Their Secretome. | 2020 Nov 15 |
9 |
| 4 |
29556305 | Tumor necrosis factor-related apoptosis inducing ligand overexpression and Taxol treatment suppresses the growth of cervical cancer cells in vitro and in vivo. | 2018 Apr |
2 |
| 5 |
29738245 | Enzyme-Responsive Charge-Reversal Polymer-Mediated Effective Gene Therapy for Intraperitoneal Tumors. | 2018 Jun 11 |
1 |
| 6 |
28758908 | Targeting Apoptotic Activity Against Prostate Cancer Stem Cells. | 2017 Jul 29 |
2 |
| 7 |
26986870 | Paclitaxel enhances tumoricidal potential of TRAIL via inhibition of MAPK in resistant gastric cancer cells. | 2016 May |
5 |
| 8 |
26315118 | Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer. | 2015 Oct 15 |
8 |
| 9 |
26547077 | Mutations Enhancing Selectivity of Antitumor Cytokine TRAIL to DR5 Receptor Increase Its Cytotoxicity against Tumor Cells. | 2015 Aug |
1 |
| 10 |
21154473 | Synergistic anticancer effects achieved by co-delivery of TRAIL and paclitaxel using cationic polymeric micelles. | 2011 Feb 11 |
1 |
| 11 |
21965726 | Paclitaxel and TRAIL synergize to kill paclitaxel-resistant small cell lung cancer cells through a caspase-independent mechanism mediated through AIF. | 2011 Oct |
2 |
| 12 |
20157422 | The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer. | 2010 Jan 18 |
2 |
| 13 |
19412666 | Generation of new TRAIL mutants DR5-A and DR5-B with improved selectivity to death receptor 5. | 2009 Jun |
1 |
| 14 |
19447545 | Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells. | 2009 Nov 1 |
2 |
| 15 |
19843632 | Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells. | 2009 Nov |
1 |
| 16 |
19957654 | [Synergistic effects and mechanisms of combined tumor necrosis factor-related apoptosis-inducing ligand and chemotherapeutic drugs or radiotherapy in killing laryngeal squamous carcinoma cells in vitro]. | 2009 Jul |
3 |
| 17 |
19996278 | Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells. | 2009 Dec |
2 |
| 18 |
18393775 | Cytoskeleton inhibitors combined with TRAIL induce apoptosis in HeLa carcinoma cells overexpressing antiapoptotic protein Bcl-2. | 2008 Mar |
1 |
| 19 |
18451172 | TRAIL inactivates the mitotic checkpoint and potentiates death induced by microtubule-targeting agents in human cancer cells. | 2008 May 1 |
2 |
| 20 |
18330255 | [Synergistic interactions of TRAIL and paclitaxel on the laryngeal squamous carcinoma cell line in vitro]. | 2007 Dec |
3 |
| 21 |
16925970 | The essential role of the mitochondria-dependent death-signaling cascade in chemotherapy-induced potentiation of Apo2L/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death. | 2006 Jul-Aug |
6 |
| 22 |
16170023 | Resistance to TRAIL is associated with defects in ceramide signaling that can be overcome by exogenous C6-ceramide without requiring down-regulation of cellular FLICE inhibitory protein. | 2005 Sep |
1 |
| 23 |
15110187 | Additive effects of TRAIL and paclitaxel on cancer cells: implications for advances in cancer therapy. | 2004 |
3 |
| 24 |
15256461 | Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival. | 2004 Jul 15 |
2 |
| 25 |
12649200 | Selective Akt inactivation and tumor necrosis actor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxel. | 2003 Mar 15 |
2 |
| 26 |
14500373 | Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. | 2003 Sep 1 |
3 |
| 27 |
14751030 | Modulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by chemotherapy in thyroid cancer cell lines. | 2003 Dec |
1 |
| 28 |
11750848 | Trail activity in human ovarian cancer cells: potentiation of the action of cytotoxic drugs. | 2002 Jan |
2 |
| 29 |
11802207 | TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer. | 2002 Feb 1 |
2 |
| 30 |
11212279 | Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. | 2001 Jan 15 |
5 |
| 31 |
9973225 | Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. | 1999 Feb 1 |
1 |